CARDIFF ONCOLOGY INC's ticker is CRDF and the CUSIP is 14147L108. A total of 59 filers reported holding CARDIFF ONCOLOGY INC in Q3 2023. The put-call ratio across all filers is 0.28 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $194,524 | -5.4% | 139,945 | 0.0% | 0.00% | – |
Q2 2023 | $205,719 | -10.9% | 139,945 | 0.0% | 0.00% | – |
Q1 2023 | $230,909 | -41.1% | 139,945 | -50.0% | 0.00% | – |
Q4 2022 | $391,846 | +81.4% | 279,890 | +100.0% | 0.00% | – |
Q3 2022 | $216,000 | -29.9% | 139,945 | 0.0% | 0.00% | – |
Q2 2022 | $308,000 | -82.4% | 139,945 | -80.1% | 0.00% | – |
Q1 2022 | $1,747,000 | -58.1% | 704,237 | +1.6% | 0.00% | – |
Q4 2021 | $4,168,000 | -0.9% | 693,445 | +9.8% | 0.00% | – |
Q3 2021 | $4,206,000 | +27.9% | 631,556 | +27.7% | 0.00% | – |
Q2 2021 | $3,288,000 | +3155.4% | 494,491 | +4413.4% | 0.00% | – |
Q1 2021 | $101,000 | -99.8% | 10,956 | -99.6% | 0.00% | -100.0% |
Q4 2020 | $45,852,000 | – | 2,548,772 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
ACT CAPITAL MANAGEMENT, LLC | 120,600 | $299,000 | 0.32% |
Artal Group S.A. | 750,000 | $1,860,000 | 0.08% |
Eventide Asset Management | 1,467,922 | $3,640,000 | 0.06% |
Atom Investors LP | 33,798 | $84,000 | 0.04% |
XTX Topco Ltd | 25,154 | $62,000 | 0.03% |
ELKHORN PARTNERS LIMITED PARTNERSHIP | 19,000 | $47,000 | 0.02% |
Engineers Gate Manager LP | 245,567 | $609,000 | 0.02% |
GSA CAPITAL PARTNERS LLP | 63,749 | $158,000 | 0.02% |
KENNEDY CAPITAL MANAGEMENT LLC | 168,902 | $419,000 | 0.01% |
Walleye Capital LLC | 123,305 | $306,000 | 0.01% |